WO2008068717A3 - A system, method, computer-readable medium, and use for planning combined therapy - Google Patents

A system, method, computer-readable medium, and use for planning combined therapy Download PDF

Info

Publication number
WO2008068717A3
WO2008068717A3 PCT/IB2007/054924 IB2007054924W WO2008068717A3 WO 2008068717 A3 WO2008068717 A3 WO 2008068717A3 IB 2007054924 W IB2007054924 W IB 2007054924W WO 2008068717 A3 WO2008068717 A3 WO 2008068717A3
Authority
WO
WIPO (PCT)
Prior art keywords
computer
readable medium
necrosis
combined therapy
planning
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2007/054924
Other languages
French (fr)
Other versions
WO2008068717A2 (en
Inventor
Jens C Georgi
Bernd Schweizer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Philips Intellectual Property and Standards GmbH
Koninklijke Philips NV
Original Assignee
Philips Intellectual Property and Standards GmbH
Koninklijke Philips Electronics NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philips Intellectual Property and Standards GmbH, Koninklijke Philips Electronics NV filed Critical Philips Intellectual Property and Standards GmbH
Priority to US12/517,717 priority Critical patent/US8663083B2/en
Priority to CN2007800452454A priority patent/CN101563041B/en
Priority to EP07849335A priority patent/EP2091453B1/en
Priority to AT07849335T priority patent/ATE466538T1/en
Priority to JP2009539857A priority patent/JP5081251B2/en
Priority to DE602007006342T priority patent/DE602007006342D1/en
Publication of WO2008068717A2 publication Critical patent/WO2008068717A2/en
Publication of WO2008068717A3 publication Critical patent/WO2008068717A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/1815—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using microwaves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00—Ultrasound therapy
    • A61N7/02—Localised ultrasound hyperthermia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B2017/00017—Electrical control of surgical instruments
    • A61B2017/00022—Sensing or detecting at the treatment site
    • A61B2017/00084—Temperature
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/36—Image-producing devices or illumination devices not otherwise provided for
    • A61B90/37—Surgical systems with images on a monitor during operation
    • A61B2090/374—NMR or MRI
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B34/00—Computer-aided surgery; Manipulators or robots specially adapted for use in surgery
    • A61B34/10—Computer-aided planning, simulation or modelling of surgical operations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/103—Treatment planning systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Surgery (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Electromagnetism (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Radiation-Therapy Devices (AREA)
  • Electrotherapy Devices (AREA)
  • Laser Surgery Devices (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Surgical Instruments (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Apparatus For Radiation Diagnosis (AREA)

Abstract

A system and method for planning a necrosis-inducing therapy and subsequent administration of a necrosis-targeting agent are described. The system takes into account the effect of necrosis-induction therapy as a basis for the biodistribution estimate of the necrosis- targeting agent. This interaction between the different calculation steps is essential for an accurate planning result. A computer-readable medium and use are also provided.
PCT/IB2007/054924 2006-12-08 2007-12-05 A system, method, computer-readable medium, and use for planning combined therapy Ceased WO2008068717A2 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
US12/517,717 US8663083B2 (en) 2006-12-08 2007-12-05 System, method, computer-readable medium, and use for planning combined therapy
CN2007800452454A CN101563041B (en) 2006-12-08 2007-12-05 A system for planning combined therapy
EP07849335A EP2091453B1 (en) 2006-12-08 2007-12-05 A system, method, computer-readable medium, and use for planning combined therapy
AT07849335T ATE466538T1 (en) 2006-12-08 2007-12-05 SYSTEM, METHOD AND COMPUTER READABLE MEDIUM AND USE FOR PROGRAMMING A COMBINATION THERAPY
JP2009539857A JP5081251B2 (en) 2006-12-08 2007-12-05 System, method, computer readable recording medium and use for planning combined therapy
DE602007006342T DE602007006342D1 (en) 2006-12-08 2007-12-05 SYSTEM, METHOD AND COMPUTER READABLE MEDIUM AND USE FOR PROGRAMMING COMBINATION THERAPY

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06125697.0 2006-12-08
EP06125697 2006-12-08

Publications (2)

Publication Number Publication Date
WO2008068717A2 WO2008068717A2 (en) 2008-06-12
WO2008068717A3 true WO2008068717A3 (en) 2008-11-06

Family

ID=39492704

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2007/054924 Ceased WO2008068717A2 (en) 2006-12-08 2007-12-05 A system, method, computer-readable medium, and use for planning combined therapy

Country Status (7)

Country Link
US (1) US8663083B2 (en)
EP (1) EP2091453B1 (en)
JP (1) JP5081251B2 (en)
CN (1) CN101563041B (en)
AT (1) ATE466538T1 (en)
DE (1) DE602007006342D1 (en)
WO (1) WO2008068717A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11654300B2 (en) 2020-01-28 2023-05-23 Reflexion Medical, Inc. Joint optimization of radionuclide and external beam radiotherapy

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6994706B2 (en) 2001-08-13 2006-02-07 Minnesota Medical Physics, Llc Apparatus and method for treatment of benign prostatic hyperplasia
WO2008079569A2 (en) 2006-11-21 2008-07-03 The Johns Hopkins University System and method for determining amount of radioactive material to administer to a patient
CN102365111B (en) * 2009-03-27 2016-06-22 皇家飞利浦电子股份有限公司 The Normal Tissue Complication probability that mark is adaptive
US8632534B2 (en) 2009-04-03 2014-01-21 Angiodynamics, Inc. Irreversible electroporation (IRE) for congestive obstructive pulmonary disease (COPD)
US9757084B2 (en) * 2011-12-22 2017-09-12 The Johns Hopkins University Method and system for administering radiopharmaceutical therapy (RPT)
US8903488B2 (en) 2009-05-28 2014-12-02 Angiodynamics, Inc. System and method for synchronizing energy delivery to the cardiac rhythm
US9895189B2 (en) 2009-06-19 2018-02-20 Angiodynamics, Inc. Methods of sterilization and treating infection using irreversible electroporation
DE102009040390A1 (en) * 2009-09-07 2011-03-17 Siemens Aktiengesellschaft Method for determining an irradiation plan, irradiation planning device and irradiation system
US9700368B2 (en) 2010-10-13 2017-07-11 Angiodynamics, Inc. System and method for electrically ablating tissue of a patient
DE102011075738A1 (en) * 2011-05-12 2012-11-15 Siemens Aktiengesellschaft Method for determining fault tolerant program for ablation of predetermined area of tissue of patient's body, involves providing a program for ablation of tissue region and choosing specific parameter values of desired ablation
US9839482B2 (en) * 2011-09-13 2017-12-12 Koninklijke Philips N.V. Ablation planning with lesion coverage feedback
US9078665B2 (en) 2011-09-28 2015-07-14 Angiodynamics, Inc. Multiple treatment zone ablation probe
EP2811901B1 (en) * 2012-02-06 2016-06-08 Insightec, Ltd. Reference-library extension during imaging of moving organs
US9414881B2 (en) 2012-02-08 2016-08-16 Angiodynamics, Inc. System and method for increasing a target zone for electrical ablation
US11116405B2 (en) * 2012-04-12 2021-09-14 Profound Medical Inc. High-intensity focused ultrasound for heating a target zone larger than the electronic focusing zone
EP2722012B1 (en) * 2012-10-18 2015-06-03 Storz Medical AG Device for shock wave treatment of the human brain
US9846765B2 (en) 2012-11-09 2017-12-19 Siemens Healthcare Gmbh System and method for patient specific modeling of liver tumor ablation
CN105208957B (en) * 2013-02-26 2019-01-22 西门子公司 System and method for interactive patient-specific simulation of radiofrequency ablation therapy
US10835313B2 (en) 2014-01-30 2020-11-17 Medlumics S.L. Radiofrequency ablation catheter with optical tissue evaluation
US10402535B2 (en) 2014-02-26 2019-09-03 Siemens Healthcare Gmbh System and method for personalized computation of tissue ablation extent based on medical images
US12114911B2 (en) 2014-08-28 2024-10-15 Angiodynamics, Inc. System and method for ablating a tissue site by electroporation with real-time pulse monitoring
WO2017137134A1 (en) * 2016-02-09 2017-08-17 Irmengard Theuer Device for the treatment of malignant diseases by using tumor-destructive mechanical pulses (tmi)
US10905492B2 (en) 2016-11-17 2021-02-02 Angiodynamics, Inc. Techniques for irreversible electroporation using a single-pole tine-style internal device communicating with an external surface electrode
DE102017214364A1 (en) * 2017-08-17 2019-02-21 Siemens Healthcare Gmbh Method for a magnetic resonance system for patient protection
JP6963677B2 (en) * 2018-03-30 2021-11-10 富士フイルム株式会社 Control method of ultrasonic diagnostic equipment and ultrasonic diagnostic equipment
US10610280B1 (en) 2019-02-02 2020-04-07 Ayad K. M. Agha Surgical method and apparatus for destruction and removal of intraperitoneal, visceral, and subcutaneous fat
WO2021214546A1 (en) * 2020-04-21 2021-10-28 Alexander Mclellan Temperature sensing catheter
CN113465778B (en) * 2021-06-21 2022-04-08 中国原子能科学研究院 How to get temperature
DE102021123863B4 (en) 2021-09-15 2024-07-04 Medizinische Hochschule Hannover, Körperschaft des öffentlichen Rechts Method and evaluation device for evaluating acquisition data of an MRI system and computer program
DE102023206383A1 (en) 2023-07-05 2025-01-09 Siemens Healthineers Ag Combined Interventional and Radiotherapy Tumor Therapy

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6241725B1 (en) * 1993-12-15 2001-06-05 Sherwood Services Ag High frequency thermal ablation of cancerous tumors and functional targets with image data assistance
US20020040220A1 (en) * 2000-07-31 2002-04-04 Roni Zvuloni Planning and facilitation systems and methods for cryosurgery

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1427813A2 (en) 2000-10-24 2004-06-16 Immunex Corporation Method for dendritic cells-based immunotherapy of tumors using combination therapy
JP2004041428A (en) * 2002-07-11 2004-02-12 Ge Medical Systems Global Technology Co Llc Treatment equipment
ES2543832T3 (en) * 2003-12-24 2015-08-24 The Regents Of The University Of California Tissue ablation with irreversible electroporation
CN100581620C (en) * 2005-12-01 2010-01-20 上海交通大学 Wide focal domain phased array focusing ultrasonic system for heating deep tumour focus
JP4448818B2 (en) * 2005-12-19 2010-04-14 株式会社デージーエス・コンピュータ Medical equipment

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6241725B1 (en) * 1993-12-15 2001-06-05 Sherwood Services Ag High frequency thermal ablation of cancerous tumors and functional targets with image data assistance
US20020040220A1 (en) * 2000-07-31 2002-04-04 Roni Zvuloni Planning and facilitation systems and methods for cryosurgery

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
ERDI ALEV K ET AL: "Use of the fast Hartley transform for three-dimensional dose calculation in radionuclide therapy", MEDICAL PHYSICS, AIP, MELVILLE, NY, US, vol. 25, no. 11, 1 November 1998 (1998-11-01), pages 2226 - 2233, XP012010360, ISSN: 0094-2405 *
HONG WAN ET AL: "Thermal Dose Optimization for Ultrasound Tissue Ablation", IEEE TRANSACTIONS ON ULTRASONICS, FERROELECTRICS ANDFREQUENCY CONTROL, IEEE SERVICE CENTER, PISCATAWAY, NJ, US, vol. 46, no. 4, 1 July 1999 (1999-07-01), pages 913 - 928, XP011090092, ISSN: 0885-3010 *
KINUYA S ET AL: "OPTIMIZATION OF RADIOIMMUNOTHERAPY INTERACTIONS WITH HYPERTHERMIA", INTERNATIONAL JOURNAL OF HYPERTHERMIA, BASINGSTOKE, GB, vol. 20, no. 2, 1 March 2004 (2004-03-01), pages 190 - 200, XP008055238, ISSN: 0265-6736 *
LAITINEN J O ET AL: "THE EFFECT OF THREE DIMENSIONAL ACTIVITY DISTRIBUTION ON THE DOSE PLANNING OF RADIOIMMUNOTHERAPY FOR PATIENTS WITH ADVANCED INTRAPERITONEAL PSEUDOMYXOMA", CANCER, AMERICAN CANCER SOCIETY, PHILADELPHIA, PA, US, vol. 80, no. 12, SUPPL, 15 December 1997 (1997-12-15), pages 2545 - 2552, XP001189085, ISSN: 0008-543X *
SGOUROS G ET AL: "THREE-DIMENSIONAL DOSIMETRY FOR RADIOIMMUNOTHERAPY TREATMENT PLANNING", JOURNAL OF NUCLEAR MEDICINE, SOCIETY OF NUCLEAR MEDICINE, RESTON, VA, US, vol. 34, no. 9, 1 September 1993 (1993-09-01), pages 1595 - 1601, XP001073461, ISSN: 0161-5505 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11654300B2 (en) 2020-01-28 2023-05-23 Reflexion Medical, Inc. Joint optimization of radionuclide and external beam radiotherapy
US12268895B2 (en) 2020-01-28 2025-04-08 Reflexion Medical, Inc. Joint optimization of radionuclide and external beam radiotherapy

Also Published As

Publication number Publication date
ATE466538T1 (en) 2010-05-15
CN101563041B (en) 2011-11-23
WO2008068717A2 (en) 2008-06-12
US20100081857A1 (en) 2010-04-01
JP5081251B2 (en) 2012-11-28
CN101563041A (en) 2009-10-21
EP2091453A2 (en) 2009-08-26
DE602007006342D1 (en) 2010-06-17
JP2010511467A (en) 2010-04-15
US8663083B2 (en) 2014-03-04
EP2091453B1 (en) 2010-05-05

Similar Documents

Publication Publication Date Title
ATE466538T1 (en) SYSTEM, METHOD AND COMPUTER READABLE MEDIUM AND USE FOR PROGRAMMING A COMBINATION THERAPY
WO2006011810A3 (en) Mr imaging method for the discrimination between healthy and tumour tissue
WO2009067605A3 (en) Preparations, methods and kits useful for treatment of cough
WO2010054114A3 (en) Cycloalkane[b]azaindole antagonists of prostaglandin d2 receptors
WO2008100805A3 (en) Anti-robo4 antibodies and uses therefor
WO2007064885A3 (en) Oral care compositions, methods, devices and systems
WO2008042216A3 (en) Methods, kits, and compositions for generating new hair follicles and growing hair
WO2012027065A3 (en) Combination therapy for treatment of disease
WO2003096255A3 (en) Simulation system for medical procedures
WO2009032737A3 (en) Systems and methods for delivering medication
WO2009086206A3 (en) Compositions and methods for joining non-conjoined lumens
WO2010060937A3 (en) Pharmaceutical combination comprising a hsp 90 inhibitor and a mtor inhibitor
WO2007149999A3 (en) Compositions and methods for joining non-conjoined lumens
EP2086317A4 (en) Nicotine formulations, kits and systems and methods for their use
WO2009024947A3 (en) Device for dialysis and stimulation of a patient and method
WO2006085906A3 (en) Method for the direct detection of diagnostic rna
MX2007001035A (en) Method of producing a composition, composition and its use.
WO2007147010A3 (en) Implantable medical devices and methods for making the same
WO2007034188A3 (en) Chemo-immunotherapy method
WO2008093256A3 (en) Determining absorbent article effectiveness
AP2350A (en) Method for the preparation of sevoflurane.
WO2010091154A3 (en) Compositions and methods for joining non-conjoined lumens
GEP20135800B (en) Method of 1-(2-halobiphenyl-4-yl)-cyclopropanecarboxylic acid derivatives preparation
UA105827C2 (en) Normal;heading 1;heading 2;heading 3;HERAPEUTIC COMBINATION OF THEOBROMINE AND AN ANTIHISTAMINE ACTING ON H1-RECEPTOR
WO2009027388A3 (en) Imaging medium comprising hyperpolarised 13c-acetate and use thereof

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200780045245.4

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07849335

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2007849335

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 12517717

Country of ref document: US

ENP Entry into the national phase

Ref document number: 2009539857

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 3936/CHENP/2009

Country of ref document: IN